These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32517085)

  • 1. Magnetic Nanomaterials as Contrast Agents for MRI.
    Caspani S; Magalhães R; Araújo JP; Sousa CT
    Materials (Basel); 2020 Jun; 13(11):. PubMed ID: 32517085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress on Manganese-Based Nanostructures as Responsive MRI Contrast Agents.
    García-Hevia L; Bañobre-López M; Gallo J
    Chemistry; 2019 Jan; 25(2):431-441. PubMed ID: 29999200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinspired, Manganese-Chelated Alginate-Polydopamine Nanomaterials for Efficient in Vivo T
    Addisu KD; Hailemeskel BZ; Mekuria SL; Andrgie AT; Lin YC; Tsai HC
    ACS Appl Mater Interfaces; 2018 Feb; 10(6):5147-5160. PubMed ID: 29277987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon Nano-Allotrope/Magnetic Nanoparticle Hybrid Nanomaterials as T2 Contrast Agents for Magnetic Resonance Imaging Applications.
    Gao Y
    J Funct Biomater; 2018 Feb; 9(1):. PubMed ID: 29415438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramagnetic inorganic nanoparticles as T1 MRI contrast agents.
    Lee SH; Kim BH; Na HB; Hyeon T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):196-209. PubMed ID: 24123961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.
    Estelrich J; Sánchez-Martín MJ; Busquets MA
    Int J Nanomedicine; 2015; 10():1727-41. PubMed ID: 25834422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.
    Zeinali Sehrig F; Majidi S; Asvadi S; Hsanzadeh A; Rasta SH; Emamverdy M; Akbarzadeh J; Jahangiri S; Farahkhiz S; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1583-8. PubMed ID: 26584684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual T
    Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F
    ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T
    Zhou H; Qiu X; Shen Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):427-444. PubMed ID: 32376585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and magnetic contrast evaluation of shape-selective Mn-Fe nanowires.
    Leung KC; Wang YX; Wang H; Xuan S; Chak CP; Cheng CH
    IEEE Trans Nanobioscience; 2009 Jun; 8(2):192-8. PubMed ID: 19435685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and MRI contrast enhancement.
    Matson ML; Wilson LJ
    Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI contrast agents: current status and future perspectives.
    Strijkers GJ; Mulder WJ; van Tilborg GA; Nicolay K
    Anticancer Agents Med Chem; 2007 May; 7(3):291-305. PubMed ID: 17504156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic properties of biofunctionalized iron oxide nanoparticles as magnetic resonance imaging contrast agents.
    Gervits NE; Gippius AA; Tkachev AV; Demikhov EI; Starchikov SS; Lyubutin IS; Vasiliev AL; Chekhonin VP; Abakumov MA; Semkina AS; Mazhuga AG
    Beilstein J Nanotechnol; 2019; 10():1964-1972. PubMed ID: 31667044
    [No Abstract]   [Full Text] [Related]  

  • 15. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions.
    Farzin L; Sheibani S; Moassesi ME; Shamsipur M
    J Biomed Mater Res A; 2019 Jan; 107(1):251-285. PubMed ID: 30358098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional nanoparticles for magnetic resonance imaging.
    Mao X; Xu J; Cui H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):814-841. PubMed ID: 27040463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents.
    Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R
    Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
    Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
    Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.